- Home
- LITB vs INKT Comparison
LITB vs INKT Comparison
Compare LITB & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LITB
- INKT
- Stock Information
- Founded
- LITB 2007
- INKT 2017
- Country
- LITB Singapore
- INKT United States
- Employees
- LITB N/A
- INKT N/A
- Industry
- LITB Catalog/Specialty Distribution
- INKT Medicinal Chemicals and Botanical Products
- Sector
- LITB Consumer Discretionary
- INKT Health Care
- Exchange
- LITB Nasdaq
- INKT Nasdaq
- Market Cap
- LITB 32.7M
- INKT 28.9M
- IPO Year
- LITB N/A
- INKT 2021
- Fundamental
- Price
- LITB $1.16
- INKT $7.25
- Analyst Decision
- LITB
- INKT Strong Buy
- Analyst Count
- LITB 0
- INKT 2
- Target Price
- LITB N/A
- INKT $37.50
- AVG Volume (30 Days)
- LITB 13.1K
- INKT 3.0K
- Earning Date
- LITB 08-01-2025
- INKT 08-12-2025
- Dividend Yield
- LITB N/A
- INKT N/A
- EPS Growth
- LITB N/A
- INKT N/A
- EPS
- LITB 0.08
- INKT N/A
- Revenue
- LITB $231,136,000.00
- INKT N/A
- Revenue This Year
- LITB N/A
- INKT N/A
- Revenue Next Year
- LITB N/A
- INKT N/A
- P/E Ratio
- LITB $15.16
- INKT N/A
- Revenue Growth
- LITB N/A
- INKT N/A
- 52 Week Low
- LITB $0.91
- INKT $4.56
- 52 Week High
- LITB $5.76
- INKT $13.79
- Technical
- Relative Strength Index (RSI)
- LITB 44.38
- INKT 47.35
- Support Level
- LITB $1.16
- INKT $7.20
- Resistance Level
- LITB $1.32
- INKT $7.57
- Average True Range (ATR)
- LITB 0.08
- INKT 0.17
- MACD
- LITB 0.01
- INKT 0.03
- Stochastic Oscillator
- LITB 14.71
- INKT 44.07
About LITB LightInTheBox Holding Co. Ltd.
LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.